: For men in early-to-mid adulthood (participants aged 28-38), 9.3% of variation in future lifespan can be predicted from a weighted combination of systolic and diastolic blood pressure, blood glucose, height, weight, and body mass index. This is marginally less than the predictable portion of variation for men and women combined. This indicates that our composite predictor is to some extent capturing male-female differences in physiology and their effect on lifespan. Figure S2 : For women in early-to-mid adulthood (participants aged 28-38), 6.6% of variation in future lifespan can be predicted from a weighted combination of systolic and diastolic blood pressure, blood glucose, height, weight, and body mass index. This is less than the predictable portion of variation for men and women combined. This indicates that our composite predictor is to some extent capturing male-female differences in physiology and their effect on lifespan. Another possible contributing factor is that more women remain alive at the latest clinical exam, so follow-up is less complete for women than for men.
Figure S3:
The individual variables' ability to predict survival in a single-time point context, stratified by gender. We see that the overall patterns of mortality-predictivity are very similar for women and men, though relatively minor di erences in the magnitude of predictable mortality and the timing o ongitudinal trends exist. As in figure 3 in the main text, blood pressure, BMI, and weight are predictive of mortality primarily from ages 35-60 and while blood glucose is most predictive from ages 57-73.
